Pregnancy Complications

Historical Context & Motivation

Throughout most of human history, pregnancy was among the most dangerous physiological states a woman could experience, with maternal mortality rates exceeding 1,000 per 100,000 live births in pre-industrial societies. The recognition and classification of pregnancy complications as distinct clinical entities — rather than an inevitable consequence of childbearing — has been one of the great triumphs of modern medicine. Understanding the historical trajectory of obstetric care provides important context for why current screening protocols, diagnostic thresholds, and management algorithms exist in their present forms.

Despite these advances, pregnancy complications remain a leading cause of maternal morbidity and mortality worldwide. The central challenge for clinicians — and for USMLE Step 2 examinees — is the ability to rapidly identify, classify, and initiate appropriate management for conditions that can progress from stable to life-threatening within hours. This lesson systematically addresses the highest-yield pregnancy complications, equipping you with the diagnostic frameworks and clinical reasoning skills tested on board examinations.

Core Principles & Classification

Pregnancy complications can be organized into several overarching categories based on the primary pathophysiological mechanism and the trimester in which they most commonly present. A structured classification schema helps clinicians prioritize differential diagnoses when a pregnant patient presents with symptoms such as bleeding, hypertension, or altered fetal status. The following foundational concepts underpin every major obstetric complication and are essential to clinical decision-making.

Visual Overview of Hypertensive Disorders in Pregnancy

The hypertensive disorders of pregnancy represent a continuum of disease severity, driven by abnormal trophoblastic invasion of the spiral arteries during the first and early second trimesters. The following diagram illustrates the spectrum of hypertensive disease, the diagnostic criteria distinguishing each entity, and the key management decision points that clinicians must navigate.

As shown in the diagram, the clinical progression from gestational hypertension to eclampsia is not always linear — patients may present de novo with severe features or HELLP syndrome without preceding mild disease. The overarching principle is that delivery is the definitive treatment for all hypertensive disorders of pregnancy. Every other intervention — magnesium sulfate for seizure prophylaxis, labetalol or hydralazine for acute blood pressure control, betamethasone for fetal lung maturity — serves only to stabilize the patient until delivery can be safely accomplished. The gestational age at which the risks of prematurity are outweighed by the risks of continuing the pregnancy defines the critical management threshold for each category.

Pathophysiology & Mechanisms

Abnormal Placentation: The Root Cause

The pathophysiology of preeclampsia is fundamentally a two-stage disease model. In Stage 1, which occurs during the first trimester, there is incomplete remodeling of the maternal spiral arteries by invasive cytotrophoblasts. Normally, these fetal-derived cells transform the narrow, muscular spiral arteries into wide, low-resistance conduits capable of supplying the massive blood flow demands of the developing placenta. When this remodeling fails, the result is uteroplacental ischemia — a persistent state of relative hypoperfusion that generates oxidative stress within the placental bed.

In Stage 2, the ischemic placenta releases a cascade of anti-angiogenic factors — most notably soluble fms-like tyrosine kinase 1 (sFlt-1) and soluble endoglin — into the maternal circulation. These factors antagonize pro-angiogenic molecules such as vascular endothelial growth factor (VEGF) and placental growth factor (PlGF), causing widespread systemic endothelial dysfunction. This endothelial injury manifests as vasospasm, increased vascular permeability, and activation of the coagulation cascade, producing the clinical triad of hypertension, proteinuria, and edema.

Key Molecular Pathways

Placental Abruption Pathophysiology

In placental abruption, the fundamental mechanism is premature separation of the normally implanted placenta from the uterine wall. This begins with rupture of maternal decidual arteries, creating a retroplacental hematoma that progressively shears the placenta away from its blood supply. Risk factors include chronic hypertension, cocaine use, abdominal trauma, and prior abruption. The clinical presentation depends on the degree of separation: partial abruption may present with vaginal bleeding and a tender, rigid uterus, while a complete or concealed abruption can cause catastrophic hemorrhagic shock with a board-like abdomen and absent fetal heart tones. Couvelaire uterus — a pathological finding of myometrial infiltration by blood — can impair uterine contractility and worsen postpartum hemorrhage.

Gestational Diabetes Mellitus: Metabolic Mechanism

Normal pregnancy induces progressive insulin resistance mediated by placental hormones including human placental lactogen (hPL), cortisol, progesterone, and tumor necrosis factor-α. In most women, pancreatic β-cells compensate by increasing insulin secretion. Gestational diabetes mellitus (GDM) develops when β-cell reserve is insufficient to overcome this physiological resistance. The resulting maternal hyperglycemia drives fetal hyperinsulinemia via facilitated diffusion of glucose across the placenta, producing fetal macrosomia, neonatal hypoglycemia, and increased risk of shoulder dystocia during delivery.

Detailed Classification of Antepartum Hemorrhage

Antepartum hemorrhage — defined as vaginal bleeding after 20 weeks of gestation — is among the most clinically urgent presentations in obstetrics. The three major etiologies are placenta previa, placental abruption, and vasa previa. Distinguishing among them rapidly is a cornerstone of obstetric emergency management and a favorite topic of board examiners.

Worked Clinical Vignette

The following clinical vignette demonstrates the systematic approach to diagnosing and managing a pregnancy complication, mirroring the format and reasoning expected on USMLE Step 2 CK.

Management Comparison: Timing of Delivery

One of the most commonly tested decision points in obstetric management is determining when to deliver. The balance between the risks of prematurity and the risks of continuing a complicated pregnancy is at the heart of obstetric care. The following table consolidates delivery timing recommendations for the major pregnancy complications, organized by the condition and its severity.

Connections to Advanced Obstetric Management

The foundational pregnancy complications covered in this lesson serve as gateways to more complex clinical scenarios tested on higher-level examinations and encountered in residency training. Understanding how these conditions interconnect and overlap is essential for developing the nuanced clinical judgment demanded of practicing obstetricians.

As you progress through your clinical training, you will encounter patients in whom multiple pregnancy complications coexist — for example, a woman with chronic hypertension who develops superimposed preeclampsia with HELLP syndrome and an abruption precipitated by the hypertensive crisis. The ability to manage these layered clinical scenarios begins with a firm command of the individual entities and their pathophysiological links, which is precisely what Step 2 examinations assess.

Practice Problems

Comprehensive Review